Skip to main content

Antimicrobial stewardship program in a pediatric intensive care unit of a tertiary care children’s hospital in Saudi Arabia – a pilot study

Introduction

Antimicrobial resistance is a serious global threat that needs urgent attention. Antimicrobial stewardship (AS) programs were proven to be effective in reducing antibiotic days in adults. Pediatric-specific data about the effectiveness of implementation of such programs are limited especially in the Middle East.

Objectives

Our primary objective was to identify the top three antibiotics and measure their specific days of therapy (DOT) per 1000 pediatric intensive care unit (PICU) days per quarter before and after the AS intervention.

Methods

We conducted a pilot prospective quality-improvement interventional study in a 20-bed PICU in a specialized tertiary care children’s hospital in Riyadh, Saudi Arabia from April to December 2014. Data about antimicrobial indication and utilization were gathered from study-designed forms. An AS member from pediatric infectious disease team rounded three times per week on all patients in PICU and provided antibiotic-related recommendations based on available bedside information and ensured adherence to antimicrobial restriction policy. Intervention also included educational sessions to physicians and nurses about proper use of antibiotics.

Results

During the study period, 648 children out of 898 PICU admissions (72.2%) were utilizing antimicrobials. Vancomycin, Pipracillin/Tazobactam and Meropenum represented approximately 60% of the 36 antimicrobials used. Per quarter, antibiotic-specific DOT dropped from 348.5 to 320.5 (8.0%, p-value <0.001) for Vancomycin, 356.2 to 294.7 (17.3%, p-value <0.001) for Pipracillin/Tazobactam, 162.0 to 111.1 (31.4%, p-value <0.001) for Meropenum.

Conclusion

Education and bedside real-time AS recommendations significantly dropped the use of Meropenum, Pipracillin/Tazobactam and Vancomycin. Moreover, AS program proved to be effective and promising in reducing antibiotic days in PICU.

Disclosure of interest

None declared.

Author information

Affiliations

Authors

Corresponding author

Correspondence to A AlDarwish.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

AlAwdah, L., AlShahrani, D., AlShehri, M. et al. Antimicrobial stewardship program in a pediatric intensive care unit of a tertiary care children’s hospital in Saudi Arabia – a pilot study. Antimicrob Resist Infect Control 4, P173 (2015). https://0-doi-org.brum.beds.ac.uk/10.1186/2047-2994-4-S1-P173

Download citation

Keywords

  • Vancomycin
  • Pediatric Intensive Care Unit
  • Antimicrobial Resistance
  • Interventional Study
  • Educational Session